Saran Kumar
Impact in
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Papers in
-
- Angiogenesis and VEGF in Cancer 3
-
- Cancer, Hypoxia, and Metabolism 5
- Protease and Inhibitor Mechanisms 4
- Cancer Genomics and Diagnostics 3
- Co-authors
- Ruowen Ge (4 shared papers)A. Waseem Malick (10 shared papers)Eli Keshet (7 shared papers)Myriam Grunewald (6 shared papers)Angappa Gunasekaran (1 shared paper)V. Raja Sreedharan (1 shared paper)P. Kalpana (1 shared paper)Maxim Mogilevsky (4 shared papers)
- Journals
- Journal of Controlled Release (5 papers)Journal of Pharmaceutical Sciences (4 papers)Pharmaceutical Research (2 papers)Scientific Reports (2 papers)Molecular Therapy — Nucleic Acids (1 paper)
- Partner nations
- IndiaUnited StatesIsrael
In The Last Decade
Saran Kumar
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 127
- Pharmaceutical Science 193
- Cancer Research 200
- Biomaterials 117
- Immunology and Allergy 48
- Dermatology 63
Countries citing papers authored by Saran Kumar
This map shows the geographic impact of Saran Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saran Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saran Kumar more than expected).
Fields of papers citing papers by Saran Kumar
This network shows the impact of papers produced by Saran Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saran Kumar. The network helps show where Saran Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Saran Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 109 | |
| 2 | 2019 | 87 | |
| 3 | 2010 | 83 | |
| 4 | 2019 | 81 | |
| 5 | 1993 | 80 | |
| 6 | 2012 | 64 | |
| 7 | 2012 | 63 | |
| 8 | 2018 | 62 | |
| 9 | 2018 | 52 | |
| 10 | 2016 | 49 | |
| 11 | 2016 | 47 | |
| 12 | 2017 | 42 | |
| 13 | 2013 | 36 | |
| 14 | 2018 | 34 | |
| 15 | 1989 | 34 | |
| 16 | 1992 | 33 | |
| 17 | 2020 | 32 | |
| 18 | 1992 | 32 | |
| 19 | 1992 | 26 | |
| 20 | 1992 | 22 |
About Saran Kumar
Saran Kumar is a scholar working on Molecular Biology, Cancer Research, Oncology, Pharmaceutical Science and Genetics, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Advancements in Transdermal Drug Delivery (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Protease and Inhibitor Mechanisms (4 papers), Cell Adhesion Molecules Research (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer Genomics and Diagnostics (3 papers) and Advanced Drug Delivery Systems (3 papers). The work is most often cited by research in Pharmaceutical Science (193 citations), Cancer Research (200 citations), Biomaterials (117 citations), Immunology and Allergy (48 citations) and Dermatology (63 citations). Saran Kumar has collaborated with scholars based in India, United States and Israel. Frequent co-authors include Ruowen Ge, A. Waseem Malick, Eli Keshet, Myriam Grunewald, Angappa Gunasekaran, V. Raja Sreedharan, P. Kalpana, Maxim Mogilevsky, Hilary Shmeeda and Alberto Gabizón. Their work appears in journals such as Journal of Controlled Release, Journal of Pharmaceutical Sciences, Pharmaceutical Research, Scientific Reports and Molecular Therapy — Nucleic Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.